Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

On Pandemics & Uncertainty: One Rheumatologist’s Story

Belinda Birnbaum, MD  |  April 24, 2020

I had a normal electrocardiogram, a normal troponin and a CT chest showing only the well-described groundglass changes and no pulmonary embolus. No one knew whether I had ongoing viral replication, reactive airways or my own mini-cytokine storm (which I decided to call a cytokine drizzle, because it wasn’t quite as bad as a storm). I wasn’t sick enough to be admitted and was sent home with albuterol.

After three days of staying in bed to avoid recurrent symptoms, I decided I needed an actual doctor instead of texting friends and colleagues. I set up a telemedicine appointment with a trusted pulmonology colleague. Just seeing his face over the computer brought me comfort. His humanity extended through the screen, as he listened to my story thoughtfully. He took me through his thinking, and he started me on prednisone. Another of my patients’ drugs, but to be fair, also his.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

My husband and I marveled at his bedside manner, more impressive when transmitted through a tiny screen. It was a lesson from a master clinician.

With the prednisone, my chest cleared over 48 hours, and I started to drink in full breaths and accept residual pain and tachycardia as deconditioning. What helped most with the uncertainty was good medical care.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Over the past two weeks, I have continued to wait to see what happens next. It is all I can do.

A New Normal
I have started to conduct telemedicine visits. The familiarity of seeing my patients, despite this new method, is reassuring—although exhausting. The usual algorithmic decisions are completely disrupted. What should we do with your biologic when your autistic son works at a supermarket? Why did you stop your biologic just when we finally got your disease under control after a year of trying? No, it’s not okay to wait to check labs if we just adjusted your methotrexate and you simultaneously started on metformin. Do we give you your rituximab for granulomatosis with polyangiitis to keep your lung disease from flaring or hold it to avoid suppressing your immune system? I dread the conversation I’ll have the next time I need to start someone on hydroxychloroquine.

I am plagued by decision fatigue and uncertainty.

So I try to channel my pulmonologist.

I try to reach through the screen and bring comfort and good decisions to my patients. We end each visit with a plan for another one, and we will see at that time what a visit looks like.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsOpinionSpeak Out Rheum Tagged with:BirnbaumCOVID-19

Related Articles

    The Story of the N95 Mask

    August 11, 2021

    On Dec. 17, 1903, at 10:35 a.m., the restraining wire was released. The Wright brothers—Orville and Wilbur—owned a bicycle sales and repair shop called the Wright Cycle Exchange, in Dayton, Ohio. At the time, the popularity of bicycles was exploding, thanks to an innovation that made them much easier (and safer) to ride. The money…

    The Many Facets of COVID-19: Experts Address Basic & Clinical Research Concepts in the COVID-19 Era

    November 23, 2021

    New concepts in autoimmunity & immunology are being discovered daily in research being conducted to understand the SARS-CoV-2 virus and its implications for rheumatology & all fields of medicine. Here are some insights shared by experts during day 1 of the Basic and Clinical Research Conference.

    Point-of-Care Testing for COVID-19

    February 16, 2021

    Ethan Craig was not pleased. As a reader of this column, you know that Dr. Craig is an assistant professor of clinical medicine in the Division of Rheumatology at the University of Pennsylvania and an associate editor of The Rheumatologist. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEOn this particular morning, however, he was the father of a…

    Vax Hesitancy? Myths & Facts for Patients

    December 16, 2021

    Although more than 189,300,000 eligible Americans are fully vaccinated against SARS-CoV-2 as of Oct. 18, 2021, vaccine hesitancy persists.1 The U.S. Centers for Disease Control and Prevention (CDC), citing data from the U.S. Census Bureau’s Household Pulse Survey collected between May 26 and June 7, 2021, reports that in some U.S. counties—particularly in the Southeast…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences